RxDoctor Payments Data

Brittney Dietz

Dayton, OHNPI 1528700135

Payments from drug & device makers

$4,066in general payments, 2019–2025

Across 143 payments — averaging $28.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$952
  • UCB, Inc.$742
  • EMD Serono, Inc.$436
  • AstraZeneca$370
  • SK Life Science, Inc.$334
  • MDD US Operations, LLC$291
  • plus $942 from 10 others

What the payments were for

  • Food & beverage$4,066100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl20$295
Levetiracetam15$230
Baclofen12$36

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →